ContributorsPublishersAdvertisers

Atsena Unveils Gene Therapy for Retinal Eye Disease with Promising Profile

biospace.com
 2021-10-18

Cover picture for the articleOn Monday, Atsena Therapeutics announced the early development of a novel spreading capsid as part of its initiative to develop a gene therapy treatment for X-linked retinoschisis. While it has yet to reach clinical trials, preclinical results with the company’s specially-tailored adeno-associated virus have been fortuitously auspicious. Retinoschisis is...

www.biospace.com

Comments / 0

Comments / 0